Second season results from the Phase 3 SMART trial were presented at the 9th RSVVW Conference and will be shared with the U.S ...

Pivotal Phase 3 global KEPLER study of vedolizumab intravenous (IV) in pediatric patients ages 2 to 17, who had an inadequate ...

For the stray vacancy round of NEET PG 2025 counselling, MCC has introduced a structured priority system to guide seat ...

A heartwarming children’s picture book series that blends imagination, emotional growth, and joyful problem-solving for ...

The reduction in depression and anxiety symptoms 3 months after completing ten AMHSP sessions indicates a slow but meaningful benefit of the programme and supports the potential of a low-intensity, ...

Realme P4 Lite launched. WhatsApp allows sharing group chat history. Amazfit T-Rex Ultra 2 launched. Google rolls out Gemini 3.1 Pro. Samsung releases revamped Bixby in beta. WZATCO Yuva Horizon ...

Full-year 2025 product and royalty revenue of $831M, exceeding guidance - - Strong Sephience (sepiapterin) uptake since 2H 2025 launch with fourth quarter and 2025 ...

Eisai Limited ("Eisai") and Biogen Canada Inc. are disappointed by and disagree with Canada's Drug Agency (CDA-AMC) that the Agency will not recommend LEQEMBI® for public reimbursement in Canada. This ...

FOP is an ultra-rare genetic disorder characterized by abnormal bone formation that infiltrates muscles, tendons, ligaments and other connective tissues, resulting in significant disability If approve ...

In other developments, lawsuits challenging the EPA endangerment rule begin and a draft GOP farm bill resurrects a pesticide ...

Researchers at Washington University School of Medicine in St. Louis have developed a method to predict when someone is likely to develop symptoms of ...

As victims of Jeffrey Epstein's crimes continued seeking justice, users flooded social media with conspiracy theories about ...